###begin article-title 0
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA,</italic>
Regulatory Polymorphisms in the Cyclophilin A Gene, PPIA, Accelerate Progression to AIDS
###end article-title 0
###begin p 1
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(PPIA),</italic>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 628 629 628 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 666 669 666 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 858 859 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1229 1233 1229 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 1364 1368 1364 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 111 114 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 123 128 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 150 155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 305 310 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 353 358 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1063 1068 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1114 1119 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1292 1297 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1372 1377 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human cyclophilin A, or CypA, encoded by the gene peptidyl prolyl isomerase A (PPIA), is incorporated into the HIV type 1 (HIV-1) virion and promotes HIV-1 infectivity by facilitating virus uncoating. We examined the effect of single nucleotide polymorphisms (SNPs) and haplotypes within the PPIA gene on HIV-1 infection and disease progression in five HIV-1 longitudinal history cohorts. Kaplan-Meier survival statistics and Cox proportional hazards model were used to assess time to AIDS outcomes. Among eight SNPs tested, two promoter SNPs (SNP3 and SNP4) in perfect linkage disequilibrium were associated with more rapid CD4+ T-cell loss (relative hazard = 3.7, p = 0.003) in African Americans. Among European Americans, these alleles were also associated with a significant trend to more rapid progression to AIDS in a multi-point categorical analysis (p = 0.005). Both SNPs showed differential nuclear protein-binding efficiencies in a gel shift assay. In addition, one SNP (SNP5) located in the 5' UTR previously shown to be associated with higher ex vivo HIV-1 replication was found to be more frequent in HIV-1-positive individuals than in those highly exposed uninfected individuals. These results implicate regulatory PPIA polymorphisms as a component of genetic susceptibility to HIV-1 infection or disease progression, affirming the important role of PPIA in HIV-1 pathogenesis.
###end p 1
###begin title 2
Author Summary
###end title 2
###begin title 3

###end title 3
###begin p 4
###xml 461 465 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 630 634 630 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 840 844 840 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 867 868 867 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1126 1130 1126 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 1221 1225 1221 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 29 32 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 97 103 <span type="species:ncbi:9606">people</span>
###xml 122 125 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 162 167 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 318 323 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 410 415 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 496 501 <span type="species:ncbi:9606">human</span>
###xml 549 554 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 643 650 <span type="species:ncbi:9606">persons</span>
###xml 691 696 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 995 1000 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1034 1039 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1168 1173 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Individual risk of acquiring HIV type 1 (HIV-1) infection and developing AIDS is not equal; some people are more prone to HIV/AIDS than others. Susceptibility to HIV-1/AIDS is likely determined by a combination of environmental, viral, and host genetic factors. Genetic variations in host cellular factors involved in HIV-1 cell entry, replication, and host defense have been found to affect susceptibility to HIV-1/AIDS. In this report, we focused on the gene PPIA that encodes cyclophilin A, a human cellular protein that is incorporated into the HIV-1 virion and promotes viral replication. We studied genetic variation in the PPIA gene in persons with different susceptibility levels to HIV-1 infection or different rates of disease progression. We found that individuals who processed two functional variants in the promoter region of PPIA had higher risk of CD4+ T-cell loss or progression to AIDS-defining diseases. We also observed that an additional variant occurred more frequently in HIV-1-infected individuals compared to HIV-1-exposed, but uninfected, individuals. These results suggest that genetic variation in PPIA may influence host susceptibility to HIV-1 infection or disease progression and targeting PPIA might provide therapeutic benefit.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b001">1</xref>
###xml 431 432 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b002">2</xref>
###xml 524 533 524 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis/trans</italic>
###xml 570 579 570 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis/trans</italic>
###xml 592 596 592 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 614 623 614 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis/trans</italic>
###xml 714 715 714 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b003">3</xref>
###xml 953 954 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b004">4</xref>
###xml 955 956 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b005">5</xref>
###xml 1158 1159 1158 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b002">2</xref>
###xml 1160 1161 1160 1161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b006">6</xref>
###xml 1247 1248 1247 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1290 1296 1290 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(PPIA)</italic>
###xml 1343 1344 1343 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b007">7</xref>
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 106 111 <span type="species:ncbi:9606">Human</span>
###xml 343 348 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 396 401 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 753 758 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 910 915 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1003 1008 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1085 1090 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1139 1144 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1193 1198 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1238 1243 <span type="species:ncbi:9606">human</span>
###xml 1405 1410 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
As an obligate intracellular parasite, HIV type 1 (HIV-1) utilizes host cell factors for its replication. Human cyclophilin A (CypA), also known as peptidyl prolyl isomerase A (PPIA), is a ubiquitous cytoplasmic protein (by convention, we refer to the protein as CypA and the gene as PPIA). CypA has long been known for its incorporation into HIV-1 virions and its important role in facilitating HIV-1 replication in host cells [1,2]. CypA is a member of the cyclophilin family, members of which all possess peptidyl-prolyl cis/trans isomerase activity. Peptidyl prolyl cis/trans isomerases (PPIAses) catalyze the cis/trans isomerization of prolyl peptide bonds and are believed to be involved in protein folding [3]. The incorporation of CypA into the HIV-1 virion capsid is mediated through the direct binding between prolyl peptide bond located in a proline-rich loop of the fourth and fifth helices of the HIV-1 capsid and the active sites of CypA [4,5]. Disruption of CypA incorporation, either by HIV-1 Gag mutations or by cyclosporine A, an immunosuppressive drug that prevents HIV-1 Gag binding to CypA, leads to an attenuation of HIV-1 infectivity [2,6]. Braaten and Luban found that HIV-1 replication was decreased in CypA-null human CD4+ T cells, in which the gene encoding CypA (PPIA) was deleted through homologous recombination [7]. CypA is therefore an important host factor that regulates HIV-1 replication.
###end p 6
###begin p 7
###xml 174 175 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b008">8</xref>
###xml 224 225 220 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b009">9</xref>
###xml 226 228 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b011">11</xref>
###xml 417 419 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b012">12</xref>
###xml 656 658 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b011">11</xref>
###xml 659 661 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b013">13</xref>
###xml 662 664 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b015">15</xref>
###xml 782 784 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b015">15</xref>
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 167 172 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 192 197 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 212 222 <span type="species:ncbi:9505">owl monkey</span>
###xml 291 296 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 359 364 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 403 408 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 600 605 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 730 735 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 774 780 <span type="species:ncbi:9606">humans</span>
Recently, the role of CypA in HIV-1 has gained even greater attention with the discovery of a fusion protein of CypA and TRIM5alpha, a host restriction factor against HIV-1 [8], which confers HIV-1 resistance in owl monkey [9-11]. Both TRIM5alpha and CypA recognize and act on the capsid of HIV-1, but apparently confer opposite effects. TRIM5alpha restricts HIV-1 by promoting premature disassembly of HIV-1 capsid [12], while CypA increases viral infectivity by facilitating proper uncoating. Although the interaction between CypA and TRIM5alpha is still unclear, it appears that the modulation of HIV-1 infectivity by CypA is independent of TRIM5alpha [11,13-15]. It has been postulated that binding of CypA to capsid protects HIV-1 from an unknown restriction factor in humans [15].
###end p 7
###begin p 8
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b016">16</xref>
###xml 329 337 329 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOBEC3G</italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b017">17</xref>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CUL5</italic>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b018">18</xref>
###xml 502 506 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b019">19</xref>
###xml 723 727 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 159 164 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 370 375 <span type="species:ncbi:9606">human</span>
###xml 383 388 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 471 474 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 554 559 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 610 615 <span type="species:ncbi:9606">human</span>
###xml 646 651 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 736 741 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 804 809 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The study of the influence of human gene variation on susceptibility to HIV-1 infection and progression is an approach that may reveal the in vivo host factor HIV-1 interactions and their epidemiologic importance at the population level. With this approach we have identified several AIDS-modifying variants in genes TRIM5 [16], APOBEC3G [17], and CUL5 [18] that encode human innate HIV-1 restriction factors or related proteins. In a recent study performed in the Swiss HIV Cohort Study, a variant of PPIA was implicated as a potential factor affecting HIV-1 disease progression [19]. As CypA is an essential human protein for completion of the HIV-1 life cycle, we have assessed the influence of genetic variation in the PPIA gene on HIV-1 infection and disease progression in five United States-based HIV-1 natural history cohorts.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Description of PPIA Variations
###end title 10
###begin p 11
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 73 81 73 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g001">Figure 1</xref>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 687 695 687 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g001">Figure 1</xref>
###xml 700 707 700 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t001">Table 1</xref>
###xml 802 803 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The PPIA gene is approximately 7 kb in length, consisting of five exons (Figure 1A). Using PPIA-specific primers we resequenced virtually the entire PPIA gene to screen for single nucleotide polymorphisms (SNPs) in 92 European Americans (EA) and 92 African Americans (AA). Seven polymorphisms were discovered: three in the putative promoter region, one in the 5' UTR, one in the 3' UTR, one in intron 4, and one in the second Alu repeat region upstream of the putative promoter. No SNPs were found in the coding regions. These SNPs and four additional SNPs available from dbSNP database located in regions not detected by our sequencing were selected for genotyping in the AIDS cohorts (Figure 1 and Table 1). SNP1 genotypes deviated from the frequencies expected under the Hardy-Weinberg equilibrium (p < 0.001), probably due to its location in the Alu repetitive element; thus, SNP1 was excluded in the analysis. SNP2 was also excluded from analysis due to its rarity. The genotypic frequencies of all other SNPs conform to Hardy-Weinberg expectations.
###end p 11
###begin p 12
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 274 282 274 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g001">Figure 1</xref>
Allele frequency distributions of PPIA SNPs differed in EA and AA with Fst values ranging from 0.03 to 0.40 (average 0.22). The difference is particularly pronounced for SNPs 7, 8, 9, 10, and 11 (Fst, 0.30-0.40), where the minor alleles are reversed in the two populations (Figure 1).
###end p 12
###begin title 13
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Linkage Disequilibrium and Haplotypes of PPIA SNPs
###end title 13
###begin p 14
###xml 137 145 137 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g002">Figure 2</xref>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g002">2</xref>
###xml 337 338 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b020">20</xref>
The extent of linkage disequilibrium (LD) among eight SNPs was assessed by calculating all pairwise D' values, separately for AA and EA (Figure 2A and 2B). Strong LD was observed among almost all SNPs in AA (D' range 0.87-1.0) and even stronger LD in EA (D' range 0.97-1.0). SNP3 and SNP4 were in perfect LD in both populations (D' = 1, r2 = 1). As each of these two SNPs carries the same information content, SNP4 was selected as a proxy for SNP3 in the analysis. The eight SNPs in both population groups formed a single LD block as defined by the solid spine of LD method [20]. This provided a justification to use all eight SNPs spanning the entire region as one block for subsequent haplotype-based association analyses.
###end p 14
###begin p 15
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b021">21</xref>
Among AA, SNP6 presented intermediate level of LD (D' ~0.60) with the SNPs downstream (SNP8-11); SNP6-SNP8 recombinant G-C haplotype had a frequency of 5%. Among EA, SNP5 had weak LD with SNP6-11 (D' 0.47-0.71); the recombinant haplotype SNP5-SNP6 (G-G) had a frequency of 2.5%. This suggests an occurrence of recombination in the region between SNP5 and SNP8. The presence of multiple Alu elements in PPIA may have introduced the recombination event by promoting genomic instability [21].
###end p 15
###begin p 16
###xml 196 204 196 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g001">Figure 1</xref>
Haplotype structure and maximum likelihood haplotype frequencies were estimated with the EM algorithm. There were, in total, eight haplotypes with minor allele frequency >1% in either population (Figure 1B). Five or six haplotypes were present in EA or AA, respectively, accounting for >97% of total sampled chromosomes. Among these, only three common haplotypes (minor allele frequency >5%) were shared between AA and EA (hap1, 2, and 4). Diverse distributions of haplotype frequencies between AA and EA were seen as for SNPs.
###end p 16
###begin title 17
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 56 61 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effect of PPIA SNPs and Haplotypes on Susceptibility to HIV-1 Infection
###end title 17
###begin p 18
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 297 304 297 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t002">Table 2</xref>
###xml 439 440 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 555 556 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 662 669 662 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t002">Table 2</xref>
###xml 119 124 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 194 199 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 261 266 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 645 650 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We compared the PPIA SNP allele and haplotype frequency distributions among three groups with increasing resistance to HIV-1 infection: seroconverters (SCs), seronegatives (SNs) belonging to an HIV-1 risk group, and those with documented high-risk exposures to HIV-1 who remain uninfected (HREU) (Table 2). The minor allele of SNP5 (G) was carried in 13.7% of SCs, 13.5% of SNs, and 9.5% of HREU, respectively (Mantel-Haenszel trend test, p = 0.21). The reduced carriage of SNP5G in HREU was significant when SCs were compared to HREU (odds ratio = 1.78, p = 0.02), suggesting that the SNP5G allele carriers may have increased susceptibility to HIV-1 infection (Table 2). No distortion of frequency distribution between risk groups were observed for all other SNPs in AA or EA (unpublished data).
###end p 18
###begin title 19
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
PPIA SNPs and AIDS Progression
###end title 19
###begin p 20
###xml 260 267 260 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t003">Table 3</xref>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 434 435 434 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 620 627 620 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t003">Table 3</xref>
We analyzed AA and EA separately since the SNP frequencies differed between the two groups. The Cox proportional hazards model was employed to test the potential differential impact of SNPs on the rates of progression to CD4 <200 or to AIDS clinical diseases (Table 3). To minimize the number of SNPs to be tested, we only tested the unique SNPs represented in each population, i.e., only one SNP was tested for those in perfect LD (r2 = 1). Six and four SNPs were analyzed in AA and EA, respectively. Two SNPs in AA (SNPs 4 and 5) and three SNPs in EA (SNPs 4, 5, and 7) showed significant or near-significant effects (Table 3).
###end p 20
###begin title 21
Effect of SNP4 on AIDS Progression
###end title 21
###begin p 22
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 215 222 215 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t003">Table 3</xref>
###xml 523 526 523 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p =</italic>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g003">Figure 3</xref>
###xml 699 706 699 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t003">Table 3</xref>
###xml 888 889 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 898 905 898 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t003">Table 3</xref>
Among AA SCs, the minor allele of SNP4 (the G allele) was associated with accelerated loss of CD4+ T cells (relative hazard [RH] = 3.7, 95% confidence interval [CI] = 1.59-8.63) in a Cox proportional hazards model (Table 3). After stratifying by cohort in the Cox regression analysis, this association became slightly stronger (RH = 4.08, 95% CI = 1.71-9.70). Kaplan-Meier survival analysis presented a clear separation of curves stratified for the SNP4 C/C and C/G genotypes (G/G absent) on progression to CD4 <200 in AA (p = 0.002, log-rank test, Figure 3). Notably, all SNP4 carriers progressed to CD4 <200 within 6 y. The effect on AIDS-1987 was in the same direction but short of significance (Table 3). Identical results were seen for SNP3 (unpublished data). Among EA SCs, a trend of accelerated progression to AIDS-1987 was also observed, though short of significance (RH = 1.34, p = 0.07, Table 3).
###end p 22
###begin p 23
###xml 174 182 174 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g004">Figure 4</xref>
###xml 547 555 547 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g004">Figure 4</xref>
###xml 757 758 757 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 767 775 767 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g004">Figure 4</xref>
###xml 866 867 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 878 886 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g004">Figure 4</xref>
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 104 110 <span type="species:ncbi:9606">people</span>
###xml 455 460 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 679 687 <span type="species:ncbi:9606">patients</span>
###xml 792 800 <span type="species:ncbi:9606">patients</span>
To affirm the observed genetic influence of SNP4, we performed a categorical analysis of HIV-1-infected people that included seroprevalents (SPs) in the long-term survivors (Figure 4). SPs who had remained AIDS-free for greater than 7.5 y for AA or 10 y for EA after study enrollment (the median time to AIDS for each) were included in this analysis. The frequency distributions of SNP4 in six discrete time intervals progressing to disease outcome after HIV-1 infection were tested for statistical trend using a Mantel-Haenszel test. As shown in Figure 4, the SNP4 G allele occurred more frequently among fast progressors in both AA and EA. With an increased sample size of 389 patients in AA, a significant trend toward rapid CD4 loss is still preserved (p = 0.04, Figure 4A). Among 970 EA patients, the trend toward rapid progression to AIDS was more pronounced (p = 0.004) (Figure 4B). Thus, the results from SC plus SP groups corroborate the findings from the SC-alone survival analyses, indicating that the accelerating effect of SNP4 is consistent in both AA and EA populations.
###end p 23
###begin title 24
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
PPIA SNP5 and AIDS Progression
###end title 24
###begin p 25
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b019">19</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b019">19</xref>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 406 413 406 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t003">Table 3</xref>
###xml 541 542 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 173 178 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In a Swiss Caucasian HIV-1 cohort, SNP5G, referred to as 1650A/G [19], was reported to be associated with a rapid CD4 cell depletion and with a trend toward higher in vitro HIV-1 replication [19]. In our analysis of EA SCs, SNP5G showed a nonsignificant trend toward rapid progression to AIDS-1987 (RH = 1.26, p = 0.08), but had no effect on CD4 cell depletion, while an opposite trend was observed in AA (Table 3). In a categorical analysis of combined samples from SCs and SPs, SNP5G also had no impact on both outcomes in both EA and AA (p > 0.23, unpublished data). Therefore, this study offers no convincing evidence for SNP5 association with disease progression in either EA or AA.
###end p 25
###begin title 26
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Effects of PPIA Haplotypes on AIDS Progression
###end title 26
###begin p 27
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 424 425 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 525 532 525 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t004">Table 4</xref>
###xml 576 584 576 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g001">Figure 1</xref>
###xml 658 665 658 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-0030088-t004">Table 4</xref>
In the haplotype analysis, we first used the Cox regression model to test the global null hypothesis of no association between haplotype frequency and AIDS progression, by comparing a model with all haplotypes to the covariants-only model. This revealed that the global distributions of haplotype frequencies were significantly or near-significantly different for the outcome of CD4 <200 in AA (p = 0.01) and AIDS-87 in EA (p = 0.08). The distortion of frequency distribution was mainly attributable to one haplotype (Hap7) (Table 4). Hap7, the only haplotype carrying SNP4G (Figure 1), was associated with accelerated progression to AIDS in both AA and EA (Table 4), consistent with the results from SNP analysis.
###end p 27
###begin title 28
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Interactions between TRIM5 and PPIA Variants
###end title 28
###begin p 29
###xml 317 321 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 363 368 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 384 389 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 520 522 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b022">22</xref>
###xml 628 629 624 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 768 770 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b011">11</xref>
###xml 771 773 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b013">13</xref>
###xml 774 776 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b015">15</xref>
###xml 777 779 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b023">23</xref>
###xml 84 89 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 442 449 <span type="species:ncbi:9606">patient</span>
###xml 483 488 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Because TRIM5alpha interferes with and CypA facilitates post-entry uncoating of the HIV-1 capsid, it is possible that there may be genetic interactions between two genes. Potential interactions were tested only between variants in two genes with functional plausibility or high strength of association. Specifically, PPIA SNP4 was tested for its interaction with TRIM5-rs16934386 and TRIM5-R136Q, which was previously reported using the same patient population to be associated with HIV-1 infection but not progression [22]. In the Cox regression model analysis, we observed no obvious interaction for infection or progression (p > 0.15, unpublished data). This suggests that CypA and TRIM5alpha likely act independently, consistent with recent in vitro observations [11,13-15,23].
###end p 29
###begin title 30
Electrophoretic Mobility-Shift Assay
###end title 30
###begin p 31
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA,</italic>
###xml 166 174 166 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g005">Figure 5</xref>
###xml 436 444 436 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g005">Figure 5</xref>
###xml 986 994 986 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g005">Figure 5</xref>
###xml 322 327 <span type="species:ncbi:9606">human</span>
As SNP3, 4, and 5 reside in the regulatory region of PPIA, we performed gel shift assays to assess whether these SNPs differentially bind to transcriptional factors (Figure 5). In this experiment, ~25-bp DNA probes containing either of the SNP alleles were incubated with the nuclear extracts from Th1 cytokine-stimulated human T lymphocytes. Both SNPs showed differential binding affinity to nuclear protein(s) with the same mobility (Figure 5A, top band). Averaged from two independent experiments, a 4-fold decrease or 2.8-fold increase in the band density was observed for the minor allele of SNP3 (G) and SNP4 (G), respectively. The cold unlabeled oligonucleotides with minor alleles were unable to compete with wild-type oligonucleotides, suggesting the bindings are specific. These results indicate that these two SNPs within the promoter alter the binding affinity with certain transcriptional protein(s). On the contrary, no obvious differential binding was observed for SNP5 (Figure 5A).
###end p 31
###begin p 32
###xml 262 270 262 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g005">Figure 5</xref>
###xml 359 360 359 360 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</underline>
###xml 531 532 531 532 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 889 893 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 994 1002 994 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-0030088-g005">Figure 5</xref>
###xml 883 888 <span type="species:ncbi:9606">human</span>
In silico analysis of the sequence at these three SNP sites by using TESS software also predicted differential binding for SNP3 and 4, but not for SNP5. SNP3 and 4 were each located in one of the consensus-binding motifs of transcription factor SP1, as shown in Figure 5B. The local sequence with SNP3C is identical to the consensus sequence of SP1 site, GGGGCC, whereas SNP3C>G change perturbs this motif. In contrast, the sequence with SNP4C has two mismatch sites compared to an alternative consensus sequence of SP1 site, GAGGCGGGGC, whereas SNP4C>G reduced the mismatch to one, predicting a stronger binding. There is, therefore, a plausible biochemical basis for the differential binding affinity observed in the gel shift experiment. These results also suggest that SNP3 and SNP4 affect transcription, likely through their interactions with SP1. The sequence of the region of human PPIA promoter resided in by SNP3 and SNP4 was compared to the corresponding sequence from other species (Figure 5C). SNP3 and SNP4 are both located in the highly conserved regions. The C allele of SNP3 is present in both primates and rodents. The C allele of SNP4 occurs only in primates and the minor allele G occurs in rodents, suggesting a possible association with speciation. These interspecies data support the hypothesis that SNP3 and SNP4 changes may have functional consequences.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b001">1</xref>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b002">2</xref>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b006">6</xref>
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b007">7</xref>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA,</italic>
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 270 275 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 313 318 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 446 451 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1031 1036 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The role of CypA in promoting HIV-1 replication has been well established through extensive in vitro experiments [1,2,6,7]. In this study, we have undertaken a systematic investigation of the association between genetic variations in the PPIA gene and susceptibility to HIV-1 infection and disease progression in HIV-1 natural history cohorts. We found that two promoter variants in perfect LD, SNP3 and SNP4, in PPIA, were associated with rapid HIV-1 disease progression. This effect was revealed for CD4 cell depletion or for AIDS progression, reflecting early or late stage of disease progression, in AA and EA, respectively. The racial difference in the strength or timing of the effects may be due to interactions with other sequence variations that are distributed differently in two populations or to immunologic and viral variables. We further found that both SNPs had differential binding efficiency to nuclear proteins in the gel shift experiment. These findings suggest that the functional promoter SNP3/SNP4 influences HIV-1 disease progression.
###end p 34
###begin p 35
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 567 571 567 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 592 596 592 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b024">24</xref>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b025">25</xref>
###xml 1287 1291 1287 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 127 140 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
###xml 233 243 <span type="species:ncbi:9598">chimpanzee</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 561 566 <span type="species:ncbi:9606">human</span>
PPIA in human encodes a 165-amino acid protein that is highly conserved across species, with 100% and 96% sequence identity to rhesus monkey and mouse, respectively. The nucleotide sequence of PPIA is 98% identical between human and chimpanzee. No variation in the coding sequence of human PPIA was found in this study or in the dbSNP database. This suggests that differential genetic impact of PPIA SNPs and haplotypes on infection and progression are likely due to regulatory region variation affecting protein levels. The regulation and promoter function of human PPIA is still undefined. PPIA is highly expressed in almost all cell types and is considered a housekeeping gene. Sequence analysis revealed that PPIA promoter contains a TATA box and two SP1 binding sites and is highly GC-rich (~70%) with overrepresented CpG dinucleotides [24]. In this study, we identified two SNPs, each located in two additional SP1 binding elements. SP1 is generally believed to function as a transactivating factor for many housekeeping genes [25]. These two SNP changes, SNP3G and SNP4G, always occurring together through LD, had opposite effects on the nuclear protein binding. Assuming the predicted stronger SP1 binding effect of SNP4 is dominant over the weaker SP1 binding of SNP3, a higher PPIA gene expression would be predicted. This would be consistent with more rapid disease course as observed in this study.
###end p 35
###begin p 36
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 483 487 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 587 588 587 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 609 610 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 620 621 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b019">19</xref>
###xml 923 924 923 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1023 1027 1023 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 1574 1578 1574 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 1703 1707 1703 1707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 365 370 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 655 658 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 790 795 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1404 1409 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1600 1605 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1744 1749 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Based on our analyses of eight SNPs covering the entire gene region of PPIA and their haplotypes, we found that the PPIA disease-modifying effects were most likely afforded by promoter SNP3 or SNP4 and the associations with the downstream SNPs 7-11 were largely due to tracking of these two SNPs through LD. In a previous report, Bleiber et al. studied the ex vivo HIV-1 infectivity in CD4+ T cells from healthy individuals carrying the SNP4 and SNP5 alleles (named as PPIA-1604 and PPIA-1650, respectively, in the Bleiber's report), as well as their impact on the CD4 gradient (from CD4+ T-cell counts 500/mm3 to 200/mm3) among SPs enrolled in the Swiss HIV cohort, largely comprised of Caucasians [19]. In the ex vivo experiment, both SNPs showed nonsignificant tendencies toward greater HIV-1 replication, with the effects of SNP5 being more pronounced. In the population study, both SNPs were associated with faster CD4+ T-cell depletion in a model also containing two other candidate genes (model 2); with the SNP5 of PPIA effect again being more pronounced. Thus, the detrimental effect of SNP4 observed from these two studies is largely consistent. In contrast, no evidence supporting a role of SNP5 in AIDS progression was found, although the SNP5 G allele was carried significantly less often in HREU than in SC but was similarly distributed in SC and SN. Thus, the role of CypA polymorphism in HIV-1 infection remains inconclusive and warrants further investigation. Taken together, the association and functional results from these two studies point to a role of PPIA genetic variation in HIV-1/AIDS. In future studies, it may be informative to determine the mechanism of association between PPIA variants and host susceptibility to HIV-1 infection or disease progression in view of the interaction between CypA and the capsid domain of the Gag polyprotein.
###end p 36
###begin p 37
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b026">26</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b027">27</xref>
###xml 618 622 618 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b019">19</xref>
###xml 227 232 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 286 291 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Population-based genetic association studies provide a powerful approach to uncovering host genes that confer disease susceptibility or resistance. This approach has led to identification of various genetic factors that affect HIV-1/AIDS, and has provided unique insights into the host HIV-1 interaction [26,27]. The successful identification of true genetic associations requires a large sample size (to minimize the type II error), replication in independent studies (to ward off type I error), and plausible functional evidence (to infer causal relationship). In this study, the plausible genetic-modifying role of PPIA is supported by replication in two independent ethnic groups and the demonstration that SNPs 3 and 4 are each associated with altered binding affinities to transcription factors. Moreover, the previous independent study also provides supportive association and functional evidence [19].
###end p 37
###begin p 38
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b028">28</xref>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b028">28</xref>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b028">28</xref>
###xml 889 893 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Our comprehensive analysis of nearly all variant alleles and their haplotypes in the PPIA gene is, in essence, equivalent to a gene-based approach [28]. A major problem facing genetic association studies is the difficulty in replication, particularly for single SNP associations. One reason for failure to replicate previous studies is due to potential differences in allele frequencies and LD structure across populations. Gene-based replication has recently been advocated as a gold standard for replication studies [28]. The entire gene with prior SNP association is considered the functional unit and is examined for association with effectively all genetic variation in the gene. Nonreplication due to population differences may be minimized as local allele frequencies and LD structure from study populations are considered with this approach [28]. Thus, our comprehensive survey of PPIA genetic variation and LD structure may facilitate future comparisons of replication studies using a gene-based approach.
###end p 38
###begin p 39
###xml 111 115 111 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b029">29</xref>
###xml 150 155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 359 364 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 436 441 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In summary, through genetic epidemiological and functional approaches, we have identified two promoter SNPs in PPIA as potential genetic modifiers of HIV-1 disease progression. Our findings corroborate the notion that genetic variation of PPIA influences AIDS pathogenesis and provide in vivo evidence that CypA is a critical host protein in interaction with HIV-1. Manipulation of PPIA may be considered as a plausible option for anti-HIV-1 therapeutic development as previously explored [29].
###end p 39
###begin title 40
Materials and Methods
###end title 40
###begin title 41
###xml 6 18 <span type="species:ncbi:9606">participants</span>
Study participants.
###end title 41
###begin p 42
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b030">30</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b031">31</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b032">32</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b033">33</xref>
###xml 1007 1009 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b034">34</xref>
###xml 6 18 <span type="species:ncbi:9606">participants</span>
###xml 77 80 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 347 350 <span type="species:ncbi:9606">men</span>
###xml 369 372 <span type="species:ncbi:9606">men</span>
###xml 374 377 <span type="species:ncbi:9606">MSM</span>
###xml 579 582 <span type="species:ncbi:9606">MSM</span>
###xml 763 771 <span type="species:ncbi:9606">children</span>
###xml 808 813 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 982 989 <span type="species:ncbi:9606">persons</span>
###xml 1048 1059 <span type="species:ncbi:9606">participant</span>
###xml 1082 1087 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1252 1257 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1574 1586 <span type="species:ncbi:9606">participants</span>
Study participants were enrolled in five United States-based natural history HIV/AIDS cohorts. AIDS Link to the Intravenous Experience (ALIVE) is a community-based cohort of intravenous injection drug users in Baltimore enrolled in 1988-1989 [30], consisting of 92% AA; Multicenter AIDS Cohort Study (MACS) is a longitudinal prospective cohort of men who have sex with men (MSM) from four United States cities: Chicago, Baltimore, Pittsburgh, and Los Angeles, enrolled in 1984-1985 [31], consisting of 83% EA and 10% AA; the San Francisco City Clinic Study (SFCC) is a cohort of MSM originally enrolled in a hepatitis B study in 1978-1980 [32], consisting of 96% EA; Hemophilia Growth and Development Study (HGDS) is a multicenter prospective study that enrolled children with hemophilia who were exposed to HIV-1 through blood products between 1982 and 1983 [33], consisting of 72% EA and 11% AA; the Multicenter Hemophilia Cohort Study (MHCS) is a prospective study that enrolled persons with hemophilia [34], consisting of 90% EA and 6% AA. The participant group is comprised of HIV-1 SCs (infected after study enrollment), SPs (infected at study enrollment), SNs, and HREU. The MACS, MHCS, SFCC, and ALIVE cohorts consist of both SCs and SPs among HIV-1-infected individuals. Due to the potential frailty bias (missing the most rapid progressors to AIDS and death) among SPs, only SCs from these four cohorts were used in the survival analysis. SPs were also included for allele frequency estimation, haplotype inference, and disease categorical analysis. The number of participants studied in each risk or disease category was as follows: SC = 654 EA, 295 AA; SN = 604 EA, 350 AA; HREU = 153 EA, 81 AA; and SP = 1199 EA, 773 AA. Of 290 AA SCs, 237, 42, 5, and 5 were from ALIVE, MACS, MHCS, and HGDS, respectively.
###end p 42
###begin p 43
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b030">30</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b035">35</xref>
###xml 133 138 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The date of seroconversion after study enrollment was estimated as the midpoint between the last seronegative and first seropositive HIV-1 antibody test; only individuals with less than 2 y elapsed time between the two tests were included in the seroconverter progression analysis. The censoring date was the earliest of the date of the last recorded visit, or December 31, 1995 for the MACS, MHCS, HGDS, and SFCC or July 31, 1997 for the ALIVE cohort to avoid potential confounding by highly effective anti-retroviral therapy (HAART). The censoring date was extended in the ALIVE cohort because of delayed uptake of HAART in this group [30,35].
###end p 43
###begin p 44
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b036">36</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b037">37</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b038">38</xref>
###xml 425 426 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 117 122 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 518 521 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-1-uninfected individuals were classified into two categories based on individual's documented exposure levels to HIV-1. HREU individuals were those 80 AA and 145 EA with documented high-risk exposure through sharing of injection equipment [36], who had anal receptive sex with multiple partners [37], or transfusions with Factor VIII clotting factor prior to 1984, when heat treatment was initiated [38]. SN individuals (n = 420 and 571, respectively, for AA and EA) are those enrolled in the cohorts who remained HIV-seronegative despite ongoing or prior risk activity.
###end p 44
###begin p 45
###xml 148 160 <span type="species:ncbi:9606">participants</span>
The study protocols were approved by the Institutional Review Boards of participating institutions and informed consent was obtained from all study participants.
###end p 45
###begin title 46
Identification of SNPs.
###end title 46
###begin p 47
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b039">39</xref>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b024">24</xref>
###xml 615 619 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 909 917 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030088-st001">Table S1</xref>
###xml 1268 1278 <span type="species:ncbi:9598">chimpanzee</span>
Nucleotide polymorphisms were discovered in a panel of 92 EA and 92 AA, representing the extremes of the distribution for rapid and slow progression to AIDS and HREU. A nonisotopic RNA cleavage assay following PCR was employed to screen for polymorphisms [39]. PPIA has a high degree of homology to multiple processed pseudogenes that varies from 75% to 95% in the exon regions. PPIA also contains six copies of Alu repeats, each with a length of approximately 300 bp, located in the immediate upstream of the putative promoter region and introns [24]. Sequence comparison and BLAST search were performed to select PPIA-specific PCR primers. Overlapping primers covered nearly the entire PPIA gene region including the putative promoter region, 5' and 3' UTRs, all five exons, as well as the Alu repeat regions. A part of intron 1 was not covered due to the high GC content. Primer sequences are presented in Table S1 and are numbered according to the GenBank DNA sequence X52851. Additional intronic SNPs were selected from NCBI dbSNP () and HapMap databases (), by considering location, spacing, and allele frequency at least 10%. Haplotype tagging (ht)SNPs were given preference in the SNP selection. The ancestral allele state of the SNPs was based on a reference chimpanzee sequence.
###end p 47
###begin title 48
Genotyping of SNPs.
###end title 48
###begin p 49
###xml 541 549 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat-0030088-st002">Table S2</xref>
Genotyping was performed using PCR-restriction fragment length polymorphism (PCR-RFLP) assay or TaqMan assays. PCR-RFLP was carried out with 35 cycles of denaturing at 94 degreesC for 30 s, annealing at 60 degreesC for 30 s, and extension at 72 degreesC for 45 s. The PCR product was digested with respective restriction enzymes (New England Biolabs, ) overnight and then separated on 3% agarose gels. TaqMan assays were obtained from the Assay-by-Demand service of Applied Biosystems (). Genotyping primers and conditions were presented in Table S2. Eight water controls were included on each plate to monitor the potential PCR contamination, and 10% of SC and HREU samples were genotyped twice. The genotypes obtained were free of water contamination or of inconsistencies between duplicates.
###end p 49
###begin title 50
Statistical analysis.
###end title 50
###begin p 51
###xml 108 109 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 282 284 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b040">40</xref>
To assess the difference in allele frequency distribution in two populations, we performed a contingency chi2 test for each marker to test the null hypothesis that the allele frequencies are the same in the two populations. Fst values were estimated by Wier and Cockerham's method [40].
###end p 51
###begin p 52
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b020">20</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b020">20</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b041">41</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b020">20</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b042">42</xref>
Pairwise LD was quantified using the absolute value of D'. Absolute values of D' range from 0 for independence to 1 for complete LD between the pairs of loci. LD plots were generated utilizing Haploview () [20]. A triangular matrix of D' value was used to demonstrate LD patterns within AA and EA. Haplotype blocks were estimated using the solid spine of LD method [20]. Haplotype blocks were defined with a default algorithm based on confidence intervals of D' [41], or the solid spine of LD method, which creates blocks of SNPs that have contiguous pairwise D' values of greater than 0.8. With the latter method, the first and last SNPs in a block are in strong LD with all intermediate SNPs, but the intermediate SNPs are not necessarily in LD with each other [20]. Eight SNP haplotype frequencies were inferred separately for each population by means of an expectation-maximization algorithm [42].
###end p 52
###begin p 53
###xml 370 375 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 470 475 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 485 490 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 494 506 <span type="species:ncbi:9606">participants</span>
###xml 586 593 <span type="species:ncbi:9606">persons</span>
###xml 635 640 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 681 686 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 722 734 <span type="species:ncbi:9606">participants</span>
Association analyses were conducted using the statistical packages SAS (version 9.0, SAS Institute, ). EA and AA groups were analyzed separately because allele and haplotype frequencies were quite different between the two groups. Conformity to the genotype frequencies expected under Hardy-Weinberg equilibrium was examined for each SNP. The genetic effects of SNPs on HIV-1 infection susceptibility were assessed by comparing allelic and genotypic frequencies between HIV-1 HREU and HIV-1 SC participants using the chi square or Fisher's exact test. Regardless of the exposure route, persons in the HREU or SN groups were at risk to HIV-1 infection based on their inclusion in a HIV-1 risk group; therefore, we combined participants across cohorts to achieve a reasonable statistical power.
###end p 53
###begin p 54
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 332 333 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b043">43</xref>
###xml 695 697 695 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 872 876 872 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 886 890 882 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 896 900 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 905 908 901 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 915 918 911 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 925 928 921 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 998 1001 994 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1044 1046 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b026">26</xref>
###xml 1047 1049 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b027">27</xref>
###xml 1053 1056 1049 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1066 1069 1062 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1099 1103 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 1109 1112 1105 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1123 1126 1119 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA</italic>
###xml 1228 1232 1224 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1372 1374 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b027">27</xref>
###xml 2168 2170 2160 2162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b044">44</xref>
###xml 266 271 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 416 421 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1210 1222 <span type="species:ncbi:9606">participants</span>
###xml 1945 1950 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Kaplan-Meier survival statistics and the Cox proportional hazards model (Cox model) were used to assess the effects of SNPs and haplotypes on the rate of progression to AIDS. Two separate endpoints reflecting advancing AIDS pathogenesis were considered for SCs: (1) HIV-1 infection plus a decline of CD4+ T-cell counts <200 cells/mm3 (CD4 <200); (2) the 1987 Center for Disease Control definition of AIDS (AIDS-87): HIV-1 infection plus AIDS-defining illness [43]. The significance of genotypic associations and RH was determined by unadjusted and adjusted Cox model regression analyses. For each SNP, we compared the minor allele genotypes to the most common genotype as a reference group. All p-values were two-tailed. Genetic factors previously shown to affect progression to AIDS were pre-determined to be included as confounding covariates in the Cox model analysis: CCR5 Delta32, CCR2-64I, CCR5-P1, HLA-B*27, HLA-B*57, HLA-B*35Px group (including HLA-B*3502, B*3503, B*3504, and B*5301), and HLA Class I homozygosity for EA (reviewed in [26,27]); HLA-B*57 and HLA Class I homozygosity for AA. CCR2-64I, HLA-B*27, and HLA-B*35Px were not considered as covariates in AA due to no or weak effects in the AA participants, and CCR5 Delta32 was not considered due to its rarity in AA. Analyses were stratified by sex and by age at seroconversion: 0-20, >20-40, and >40 y [27]. Further stratification by cohort was also performed for the exploratory analyses. In the stratified Cox regression model, the overall log-likelihood of hazards obtained is the sum over strata of the stratum-specific hazards, as estimated by the method of partial likelihood. As the same criteria for determining startpoints (seroconversion date) and endpoints and the similar sampling strategy and follow-up settings were used across cohorts, we combined SCs from all cohorts for the survival analysis to increase the power. Although these cohorts differ in routes of HIV-1 transmission, no appreciable effect of mode of infection on AIDS progression has been found through re-analysis of more than ten thousands of SCs from 38 studies around the world (including three used in this study) [44].
###end p 54
###begin p 55
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 492 493 492 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To test the association of PPIA haplotypes and HIV-1 disease progression, we first performed a global test in the Cox regression model for each of two disease outcomes separately for AA and EA. The global null hypothesis is that the odds ratios of all haplotypes are equal between cases and controls. Likelihood ratio tests were used to compare a full model with all haplotypes and a base model with only covariates. When the significance of the global test exceeded a relaxed nominal level, p < 0.10, the associations of individual haplotypes were further tested.
###end p 55
###begin p 56
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b045">45</xref>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA.</italic>
###xml 365 367 365 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p-</italic>
###xml 404 405 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 526 527 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
To assess the level of correction factor for the number of SNPs, assuming this was a discovery study, we applied spectral decomposition analysis [45]. This multiple testing correction method assesses the equivalent level of independent SNPs taking account of the extensive LD across PPIA. Based on spectral decomposition analysis of SNPs in this study, a corrected p-value of 0.01 would be equivalent to p = 0.05. As this study was a confirmation and extension study of markers with previous positive association, uncorrected p-values were reported.
###end p 56
###begin title 57
Electrophoretic mobility-shift assay.
###end title 57
###begin p 58
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat-0030088-b046">46</xref>
###xml 109 114 <span type="species:ncbi:9606">human</span>
###xml 582 587 <span type="species:ncbi:9606">human</span>
Cell culture and an electrophoretic mobility-shift assay were performed as described [46]. Freshly explanted human T lymphocytes were obtained from normal donors, purified by isocentrifugation, and activated for 72 h with 1 mg/ml PHA in RPMI 1640 medium containing 10% FCS (Sigma, ), 2 mM L-glutamine, and penicillin-streptomycin (50 IU/ml and 50 mg/ml, respectively). T lymphocytes were made quiescent by washing and incubating for 24 h in RPMI 1640 medium containing 1% FCS before exposure to cytokines. Cells were then stimulated with 100 nmol/L IL-4 (PeproTech, ) or 100 nmol/L human rIL-2 (Hoffmann-La Roche, ) at 37 degreesC for 10 min. Cell pellets were frozen at -70 degreesC. The probe sequences were 5'-ttgcgggcggggCcgaacgtggtat-3' for SNP3C and ttgcgggcggggGcgaacgtggtat-3' for SNP3G; 5'- ggcgggaggcCaggctcgtgccgtt for SNP4C, and 5'- ggcgggaggcGaggctcgtgccgtt-3' for SNP4G allele; 5'-aggaaaaccgtgtActattagccatggt-3' for SNP5A and 5'-aggaaaaccgtgtGctattagccatggt-3' for SNP5G (SNP site is capped). In cold oligonucleotide competition assay, 100-fold excess of cold unlabeled probe was added as a competitor. The band density was measured by using the software ImageJ (). The sequence in and around the SNP sites in the promoter region were searched for the presence of transcription factor binding sites using the program TESS: Transcription Element Search System (). Sequence alignment was performed using program ClustalW ().
###end p 58
###begin title 59
Supporting Information
###end title 59
###begin title 60
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Primers Used in the Resequencing of the PPIA Gene
###end title 60
###begin p 61
(17 KB XLS)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin title 63
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Genotyping Methods for PPIA SNPs
###end title 63
###begin p 64
(18 KB XLS)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin title 66
Accession Numbers
###end title 66
###begin p 67
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRIM5</italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 170 180 <span type="species:ncbi:9598">chimpanzee</span>
The Entrez Gene databank () accession numbers for the genes mentioned in this paper are PPIA (5478) and TRIM5 (85363). The GenBank () accession numbers for the human and chimpanzee PPIA genomic sequence are X52851 and NW_001237949, respectively. The Transfac binding site () accession number is R04195 and R03868 for the SP1 factor.
###end p 67
###begin p 68
We thank Yuchun Zhou and Beth Binns-Roemer for excellent technical assistance.
###end p 68
###begin title 69
Abbreviations
###end title 69
###begin p 70
African American
###end p 70
###begin p 71
confidence interval
###end p 71
###begin p 72
cyclophilin A
###end p 72
###begin p 73
European American
###end p 73
###begin p 74
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV type 1
###end p 74
###begin p 75
high-risk exposed uninfected
###end p 75
###begin p 76
linkage disequilibrium
###end p 76
###begin p 77
peptidylprolyl isomerase A
###end p 77
###begin p 78
relative hazard
###end p 78
###begin p 79
seroconverter
###end p 79
###begin p 80
seronegative
###end p 80
###begin p 81
single nucleotide polymorphism
###end p 81
###begin p 82
seroprevalent
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B
###end article-title 84
###begin article-title 85
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Specific incorporation of cyclophilin A into HIV-1 virions
###end article-title 85
###begin article-title 86
Protein folding. Prolyl isomerases join the fold
###end article-title 86
###begin article-title 87
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid
###end article-title 87
###begin article-title 88
###xml 66 101 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein
###end article-title 88
###begin article-title 89
###xml 45 50 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Functional association of cyclophilin A with HIV-1 virions
###end article-title 89
###begin article-title 90
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells
###end article-title 90
###begin article-title 91
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys
###end article-title 91
###begin article-title 92
###xml 53 63 <span type="species:ncbi:9505">owl monkey</span>
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1
###end article-title 92
###begin article-title 93
###xml 46 56 <span type="species:ncbi:9505">owl monkey</span>
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1
###end article-title 93
###begin article-title 94
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells
###end article-title 94
###begin article-title 95
Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor
###end article-title 95
###begin article-title 96
###xml 48 83 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
Cyclophilin A and TRIM5a independently regulate human immunodeficiency virus type 1 infectivity in human cells
###end article-title 96
###begin article-title 97
###xml 85 90 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin A: An auxiliary but not necessary cofactor for TRIM5alpha restriction of HIV-1
###end article-title 97
###begin article-title 98
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cyclophilin, TRIM5, and innate immunity to HIV-1
###end article-title 98
###begin article-title 99
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 91 119 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection
###end article-title 99
###begin article-title 100
APOBEC3G genetic variants and their influence on the progression to AIDS
###end article-title 100
###begin article-title 101
###xml 45 46 45 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals
###end article-title 101
###begin article-title 102
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 99 134 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Use of a combined ex vivo/in vivo population approach for screening of human genes involved in the human immunodeficiency virus type 1 life cycle for variants influencing disease progression
###end article-title 102
###begin article-title 103
Haploview: Analysis and visualization of LD and haplotype maps
###end article-title 103
###begin article-title 104
###xml 16 21 <span type="species:ncbi:9606">human</span>
Alu repeats and human genomic diversity
###end article-title 104
###begin article-title 105
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 91 119 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection
###end article-title 105
###begin article-title 106
###xml 39 74 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 123 128 <span type="species:ncbi:9606">human</span>
Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells
###end article-title 106
###begin article-title 107
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human cyclophilin gene and of related processed pseudogenes
###end article-title 107
###begin article-title 108
The Sp-family of transcription factors
###end article-title 108
###begin article-title 109
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human genes that limit AIDS
###end article-title 109
###begin article-title 110
###xml 57 60 <span type="species:ncbi:9606">man</span>
Polygenic and multifactorial disease gene association in man: Lessons from AIDS
###end article-title 110
###begin article-title 111
The future of association studies: Gene-based analysis and replication
###end article-title 111
###begin article-title 112
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A
###end article-title 112
###begin article-title 113
###xml 63 66 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: Plasma viral load and CD4+ cell count
###end article-title 113
###begin article-title 114
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
###end article-title 114
###begin article-title 115
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Long-term HIV-1 infection without immunologic progression
###end article-title 115
###begin article-title 116
Hemophilia growth and development study. Design, methods, and entry data
###end article-title 116
###begin article-title 117
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia
###end article-title 117
###begin article-title 118
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users
###end article-title 118
###begin article-title 119
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Perspectives on infection with HIV-1 among intravenous drug users
###end article-title 119
###begin article-title 120
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Resistance to HIV-1 infection. Multicenter AIDS Cohort Study
###end article-title 120
###begin article-title 121
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Characterization of high-risk HIV-1 seronegative hemophiliacs
###end article-title 121
###begin article-title 122
NIRCA: A rapid robust method for screening for unknown point mutations
###end article-title 122
###begin article-title 123
Estimating F-statistics for the analysis of population structure
###end article-title 123
###begin article-title 124
###xml 41 46 <span type="species:ncbi:9606">human</span>
The structure of haplotype blocks in the human genome
###end article-title 124
###begin article-title 125
An E-M algorithm and testing strategy for multiple-locus haplotypes
###end article-title 125
###begin article-title 126
Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
###end article-title 126
###begin article-title 127
###xml 10 15 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 184 187 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly active antiretroviral therapy: A collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe
###end article-title 127
###begin article-title 128
A simple correction for multiple testing for single nucleotide polymorphisms in linkage disequilibrium with each other
###end article-title 128
###begin article-title 129
JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T-cell response
###end article-title 129
###begin title 130
Figures and Tables
###end title 130
###begin title 131
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 38 43 <span type="species:ncbi:9606">Human</span>
Gene Map, SNPs, and Haplotypes in the Human PPIA on Chromosome 7p13
###end title 131
###begin p 132
###xml 230 240 <span type="species:ncbi:9598">chimpanzee</span>
Coding exons are marked by green blocks, and 5' and 3' UTRs by light green blocks. Hatched black boxes represent Alu repeats. Haplotype structure and frequencies are shown in the middle panel. The corresponding nucleotides in the chimpanzee and allele frequencies of the SNPs are presented in the bottom panel. MAF, minor allele frequency of SNPs (based on EA frequency).
###end p 132
###begin title 133
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
LD Structure of PPIA SNPs in AA and EA
###end title 133
###begin p 134
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
LD Structure of PPIA SNPs in AA (A) and EA (B). Pairwise D' plots and haplotype blocks obtained from HAPLOVIEW. Pairwise D' values (%) were indicated in triangle squares except for those of D' of 1.0. High D' values were shown in bright red (LOD >= 2) or light blue squares (LOD < 2), and low D' values were shown in light red (LOD >= 2) and white squares (LOD < 2). Single haplotype block was defined by the solid spine algorithm.
###end p 134
###begin title 135
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
Kaplan-Meier Survival Curve Analysis of SNP4 on Progression to CD4+ Cells <200/mm3 in AA
###end title 135
###begin title 136
Disease Categorical Analysis Using both SCs and SPs for the Effect of SNP4 on Progression to CD4 <200 in AA and to AIDS-87 in EA
###end title 136
###begin p 137
###xml 304 305 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
Only SPs with greater than 7.5 y (for AA [A]) or 10 y (for EA [B]) of survival time, the median survival time of the SCs, were included in the analysis. The frequencies of the SNP4 C/G genotype in five intervals after seroconversion are plotted and tested for statistical trends using Mantel-Haenszel chi2 test. Numbers of patients are listed above the bar.
###end p 137
###begin title 138
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Binding Affinity of Nuclear Factors to the SNP-Containing Fragments in the 5' Regulatory Regions of PPIA and the Sequence Context of the Region
###end title 138
###begin p 139
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA.</italic>
###xml 106 111 <span type="species:ncbi:9606">human</span>
(A) Gel shift analysis of SNP3, SNP4, and SNP5 in the 5' regulatory region of PPIA. Nuclear extracts from human T lymphocytes induced by IL4 were bound to the DNA fragment containing the C or G allele of SNP3, the C or G allele of SNP4, and the A or G allele of SNP5, respectively. The arrowhead indicates the band showing differential binding of nuclear factor(s) to the oligonucleotides. The bands below the arrow may represent nonspecific complexes and the bands at the bottom are free probes.
###end p 139
###begin p 140
(B) Sequence context of SNP3 and SNP4 and comparison to the consensus-binding motifs of transcription factor SP1. SNPs 3 and 4 (located at positions 1575 and 1604 in the sequence X52851, and -85 and -59, to the ATG start codon, respectively) are in perfect LD. SNP3C>G change predicts a loss of binding to a SP1 factor, while SNP4C>G change predicts a stronger binding to a SP1 factor.
###end p 140
###begin p 141
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
(C) The interspecies alignments of a segment of the PPIA promoter containing SNP3 and SNP4. Conserved regions are underlined and SNP sites are colored.
###end p 141
###begin p 142
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Characterization of PPIA SNPs
###end p 142
###begin p 143
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Effects of PPIA SNP4 and SNP5 on HIV-1 Infection Risk in EA
###end p 143
###begin p 144
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Effects of PPIA SNPs on AIDS Progression in AA and EA
###end p 144
###begin p 145
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPIA</italic>
Effects of PPIA Haplotypes on AIDS Progression
###end p 145
###begin p 146
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
Author contributions. PA, SJO, and CAW conceived and designed the experiments and wrote the paper. PA, LHW, and HHD performed the experiments. PA and CAW analyzed the data. GN, SD, JJG, CRR, SB, GDK, and SJO contributed reagents/materials/analysis tools.
###end p 146
###begin p 147
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding.</bold>
###xml 350 355 <span type="species:ncbi:9606">Human</span>
###xml 627 632 <span type="species:ncbi:9606">Human</span>
Funding. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and National Human Genome Research Institute. The National Institute on Drug Abuse, National Institutes of Health, under grant DA-04334 provided funding for the ALIVE cohort. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
###end p 147
###begin p 148
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing interests.</bold>
Competing interests. The authors have declared that no competing interests exist.
###end p 148

